Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of Qualitek Labs Limited at its meeting held on 20th December, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Qualitek Labs Limited's Board, at its meeting on 20 December 2025, approved the issuance of secured, unlisted, redeemable Non-Convertible Debentures (NCDs) on a private placement basis. The issue size is up to ₹65 Crore, with each NCD carrying a face value of ₹1,00,000, implying up to 6,500 NCDs. The NCDs will not be listed on any stock exchange. Vistra ITCL (India) Limited has been appointed as the Debenture Trustee. The issue will be backed by mortgages/hypothecation on movable and immovable assets, pledge of shares, escrow and DSRA accounts, and corporate and personal guarantees from promoters and group entities. Tenure, coupon rate, and redemption schedule remain to be finalized. An EGM will be convened to seek shareholder approval under Section 180(1)(a) and for any material related party transactions.
The company is raising up to ₹65 Crore of debt, which will bolster liquidity but add to repayment obligations and create security over its assets. Promoters are pledging personal guarantees, signaling their commitment, but shareholders should watch for the EGM outcome and the final coupon rate, which will indicate the cost of this borrowing.